BENEPALI — Total Revenue
Biogen BENEPALI — Total Revenue increased by 13.2% to $122.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from $111.30M to $122.10M. Over 4 years (FY 2021 to FY 2025), BENEPALI — Total Revenue shows relatively stable performance with a -2.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market adoption, successful commercialization, or improved pricing power for the asset, while a decrease may signal increased competition, patent expiration, or loss of market share.
Detailed definition
This metric represents the total gross revenue generated from the sale of the specified pharmaceutical product or therap...
Peer comparison
Comparable to product-level revenue reporting in other biopharmaceutical companies, often benchmarked against similar therapeutic class competitors or biosimilar market performance.
biib_segment_benepali_total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $121.50M | $120.80M | $134.30M | $114.70M | $115.80M | $110.20M | $100.30M | $109.00M | $109.20M | $112.80M | $107.80M | $118.70M | $117.30M | $118.10M | $125.00M | $111.30M | $112.10M | $121.90M | $107.90M | $122.10M |
| QoQ Change | — | -0.6% | +11.2% | -14.6% | +1.0% | -4.8% | -9.0% | +8.7% | +0.2% | +3.3% | -4.4% | +10.1% | -1.2% | +0.7% | +5.8% | -11.0% | +0.7% | +8.7% | -11.5% | +13.2% |
| YoY Change | — | — | — | — | -4.7% | -8.8% | -25.3% | -5.0% | -5.7% | +2.4% | +7.5% | +8.9% | +7.4% | +4.7% | +16.0% | -6.2% | -4.4% | +3.2% | -13.7% | +9.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's benepali — total revenue?
- Biogen (BIIB) reported benepali — total revenue of $122.10M in Q1 2026.
- How has Biogen's benepali — total revenue changed year-over-year?
- Biogen's benepali — total revenue increased by 9.7% year-over-year, from $111.30M to $122.10M.
- What is the long-term trend for Biogen's benepali — total revenue?
- Over 4 years (2021 to 2025), Biogen's benepali — total revenue has grown at a -2.3% compound annual growth rate (CAGR), from $498.30M to $453.20M.
- What does benepali — total revenue mean?
- The total sales revenue generated by the specific pharmaceutical product or therapeutic asset.